DENVER – The Colorado Department of Public Health and Environment is working with other western states and the CDC to investigate illnesses due to E. coli O157:H7 from chicken salad purchased at Colorado Costco stores in late October.
Consumers with “Chicken Salad made with Rotisserie Chicken” – item number 37719 – purchased from Costco in Colorado should discard it.
Four cases of E. coli O157:H7 have been confirmed in Colorado, including two cases in Jefferson County and one each in Arapahoe and Routt counties. One person was hospitalized; all have recovered. The individuals purchased the product on Oct. 25 and 26 and became ill between Oct. 28 and Nov. 3.
The FDA, USDA-FSIS, and CDC are working with Costco to determine the source of contamination.
Other states with confirmed E. coli cases linked to the chicken salad include Utah, Montana and Washington.
“We are working with Costco,” said Alicia Cronquist, an epidemiologist at the Colorado Department of Public Health and Environment. “FDA reported to us the product has been removed from the shelves and no longer is for sale in Colorado.”
People who have eaten the product and feel ill should consult with their health care provider.
The Colorado Department of Public Health andEnvironment (CDPHE) is investigating an E. coli O157:H7 outbreak linked to chicken salad purchased at Costco stores in that state in late October. At least four people have been sickened with E. coli O157:H7 infections in Colorado. Other states with confirmed E. coli cases linked to Costco chicken salad are Utah, Montana, and Washington.
An E. coli outbreak linked to chicken salad sold Costco stores has sickened 19 people in seven states. Five people have been hospitalized, two of them have hemolytic uremic syndrome (HUS), a life-threatening complication that causes kidney failure, seizure, stroke and coma.
CDC, the U.S. Food and Drug Administration, the U.S. Department of Agriculture Food Safety and Inspection Service, and public health officials in several states are investigating an outbreak of Shiga toxin-producing Escherichia coli O157:H7 (STEC O157:H7) infections.A total of 19 people infected with the outbreak strain of Shiga toxin-producing STEC O157:H7 have been reported from 7 states. The majority of illnesses have been reported from states in the western United States. The number of ill people reported from each state is as follows: California (1), Colorado (4), Missouri (1), Montana (6), Utah (5), Virginia (1), and Washington (1).
Erze Ambalaj, the largest producer of expanding foam packaging for food in Turkey, together with Parx Plastics has developed antimicrobial packaging that significantly reduces the growth of Salmonella, Listeria, E.Coli and Staphylococcus Aureus in food packaging.
Forty-five people infected with the outbreak strain of STEC O26 have been reported from 6 states. The majority of illnesses have been reported from Washington and Oregon. The number of ill people reported from each state is as follows: California (2), Minnesota (2), New York (1), Ohio (1), Oregon (13), and Washington (26).
An E. coli outbreak that sickened at least 42 people and shuttered Chipotle restaurants in Oregon and Washington was another recent reminder of the impact of food-related or foodborne illness. In the next year, studies suggest that nearly one in 30 Americans — 10 million people — will get sick from a foodborne pathogen, and one in 250,000 will die.
The U.S. economy will take a $15.5 billion dollar hit through lost income, lost revenue, healthcare-related costs and some intangibles, like “pain and suffering,” according to the U.S. Department of Agriculture.
Research -ECDC publishes 2014 surveillance data on antimicrobial resistance and antimicrobial consumption in Europe
In relation to the 8th European Antibiotic Awareness Day on 18 November, the European Centre for Disease Prevention and Control (ECDC) has published the annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) . On the same occasion, an update with 2014 data of the EARS-Net interactive database on antimicrobial resistance  and the European Surveillance of Antimicrobial Consumption Network (ESAC-Net) interactive database on antimicrobial consumption  was released, on the ECDC website.
The data on antimicrobial resistance showed that the percentages of Klebsiella pneumoniae isolates resistant to fluoroquinolones, third-generation cephalosporins and aminoglycosides, as well as combined resistance to all three antibiotic groups increased significantly at European Union (EU)/European Economic Area (EEA) level over the last four years. A significant increase was also observed for carbapenem resistance in K. pneumoniae.
For Escherichia coli, resistance to third-generation cephalosporins and combined resistance to fluoroquinolones, third-generation cephalosporins and aminoglycosides increased significantly at EU/EEA level. The increase in combined resistance, and the increase in resistance to last line groups of antimicrobials such as the carbapenems, is a serious cause for concern and a threat to patient safety in Europe.
Data on antimicrobial consumption in 2014 show that the overall consumption of antimicrobials in the community in the EU/EEA was 21.6 defined daily doses (DDD) per 1,000 inhabitants and per day. The large inter-country variation in antibiotic consumption observed in previous years remained. When antibiotic consumption was expressed in terms of number of packages (a better estimate for prescriptions) per 1,000 inhabitants and per day, five countries (Denmark, Luxembourg, Slovenia, Spain and Sweden) showed a significant decrease during 2010–2014.
During the same period, antibiotic consumption in the hospital sector (expressed in DDD per 1,000 inhabitants and per day) showed a significant increasing trend. A significant increase in the consumption of specific antibiotic groups, e.g. carbapenems, was also observed during this period at EU/EEA level, and in several countries. Although the vast majority of antibiotics is consumed in the community, i.e. outside hospitals, antibiotic consumption in hospitals is a major driver of the spread of multidrug-resistant bacteria responsible for healthcare-associated infections.
The FDA Food Safety Modernization Act is based on preventing problems before they happen, rather than solely responding to outbreaks of foodborne illness. But in order to develop prevention-based systems, you need data and other information to help identify hazards that need to be addressed and minimized.
That is why sampling is an important part of this preventive approach and why the FDA is developing a new microbiological surveillance sampling model designed to identify patterns that may help predict and prevent future contamination by disease-causing bacteria.
This new proactive and preventive approach was developed in 2014 and is part of FDA’s efforts to further protect the food supply by keeping contaminated food from reaching consumers. The FDA will publicly share the data it receives through this approach and will engage stakeholders throughout the process.
Surveillance sampling is just one type of sampling that is important for food safety. There are different kinds of sampling, and the methods that the FDA uses fall into three broad categories: environmental, product, and emergency response/emerging issues sampling.
CDC updated the information regarding the outbreak of Salmonella related to contaminated cucumbers that began in July. There have been 838 cases of Salmonella reported in 38 states with 165 hospitalizations and 4 deaths.